Autonomic dysfunction is associated with neuropsychological impairment in Lewy body disease.


Journal

Journal of neurology
ISSN: 1432-1459
Titre abrégé: J Neurol
Pays: Germany
ID NLM: 0423161

Informations de publication

Date de publication:
Jul 2020
Historique:
received: 13 01 2020
accepted: 04 03 2020
revised: 02 03 2020
pubmed: 15 3 2020
medline: 13 4 2021
entrez: 15 3 2020
Statut: ppublish

Résumé

This study aimed to analyze the association of autonomic dysfunction with cognition, depression, apathy, and fatigue in Lewy body disease (LBD). We included 61 patients [49 with idiopathic Parkinson's disease, 7 with dementia with Lewy bodies, and 5 E46K-SNCA mutation carriers] and 22 healthy controls. All participants underwent a comprehensive battery of neuropsychological and clinical measures, autonomic symptom assessment with the SCOPA-AUT, analysis of non-invasive hemodynamic parameters during deep breathing, the Valsalva maneuver, and a 20-min tilt test, and electrochemical skin conductance measurement at rest (Sudoscan). Student's t tests were used to assess group differences, and bivariate correlations and stepwise linear regressions to explore associations between autonomic function, cognition, depression, apathy, and fatigue. Compared to controls, patients who had significant impairment (p < 0.05) in cognition, higher depression, apathy, and fatigue, more autonomic symptoms and objective autonomic dysfunction, reduced deep breathing heart rate variability [expiratory-to-inspiratory (E/I) ratio], prolonged pressure recovery time, and lower blood pressure in Valsalva late phase II and phase IV, while 24.1% had orthostatic hypotension in the tilt test. Autonomic parameters significantly correlated with cognitive and neuropsychiatric outcomes, systolic blood pressure during the Valsalva maneuver predicting apathy and depression. The E/I ratio was the main predictor of cognitive performance (17.6% for verbal fluency to 32.8% for visual memory). Cardiovascular autonomic dysfunction is associated with cognitive and neuropsychiatric impairment in LBD, heart rate variability during deep breathing and systolic blood pressure changes during the Valsalva procedure are the main predictors of neuropsychological performance and depression/apathy symptoms, respectively.

Identifiants

pubmed: 32170444
doi: 10.1007/s00415-020-09783-7
pii: 10.1007/s00415-020-09783-7
doi:

Substances chimiques

SNCA protein, human 0
alpha-Synuclein 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1941-1951

Subventions

Organisme : Michael J. Fox Foundation for Parkinson's Research
ID : 10189
Organisme : Instituto de Salud Carlos III
ID : PI14/00679
Organisme : Instituto de Salud Carlos III
ID : PI16/00005
Organisme : Juan Rodes
ID : JR15/00008
Organisme : Eusko Jaurlaritza
ID : 2016111009

Références

Schapira AHV, Chaudhuri KR, Jenner P (2017) Non-motor features of Parkinson disease. Nat Rev Neurosci 18(7):435–450. https://doi.org/10.1038/nrn.2017.62
doi: 10.1038/nrn.2017.62 pubmed: 28592904
Bernal-Pacheco O, Limotai N, Go CL, Fernandez HH (2012) Nonmotor manifestations in Parkinson disease. The Neurologist 18(1):1–16. https://doi.org/10.1097/NRL.0b013e31823d7abb
doi: 10.1097/NRL.0b013e31823d7abb pubmed: 22217609
Berganzo K, Tijero B, Gonzalez-Eizaguirre A, Somme J, Lezcano E, Gabilondo I, Fernandez M, Zarranz JJ, Gomez-Esteban JC (2016) Motor and non-motor symptoms of Parkinson's disease and their impact on quality of life and on different clinical subgroups. Neurologia (Barcelona, Spain) 31(9):585–591. https://doi.org/10.1016/j.nrl.2014.10.010
doi: 10.1016/j.nrl.2014.10.010
Tijero B, Gomez-Esteban JC, Lezcano E, Fernandez-Gonzalez C, Somme J, Llorens V, Martinez A, Ruiz-Martinez J, Foncea N, Escalza I, Berganzo K, Aniel-Quiroga MA, Ruiz V, Teran N, Kaufmann H, Zarranz JJ (2013) Cardiac sympathetic denervation in symptomatic and asymptomatic carriers of the E46K mutation in the alpha synuclein gene. Parkinsonism Relat Disord 19(1):95–100. https://doi.org/10.1016/j.parkreldis.2012.08.001
doi: 10.1016/j.parkreldis.2012.08.001 pubmed: 23000061
Bosboom JL, Stoffers D, Wolters E (2004) Cognitive dysfunction and dementia in Parkinson's disease. J Neural Transm (Vienna, Austria: 1996) 111(10–11):1303–1315. https://doi.org/10.1007/s00702-004-0168-1
doi: 10.1007/s00702-004-0168-1
Goldman JG, Williams-Gray C, Barker RA, Duda JE, Galvin JE (2014) The spectrum of cognitive impairment in Lewy body diseases. Mov Disord 29(5):608–621. https://doi.org/10.1002/mds.25866
doi: 10.1002/mds.25866 pubmed: 24757110 pmcid: 4126402
Emre M (2003) Dementia associated with Parkinson's disease. The Lancet Neurol 2(4):229–237
doi: 10.1016/S1474-4422(03)00351-X
Gomperts SN (2016) Lewy body dementias: dementia with Lewy bodies and Parkinson Disease Dementia. Continuum (Minneapolis, Minn) 22(2 Dementia):435–463. https://doi.org/10.1212/con.0000000000000309
doi: 10.1212/con.0000000000000309
Aarsland D, Creese B, Politis M, Chaudhuri KR, Ffytche DH, Weintraub D, Ballard C (2017) Cognitive decline in Parkinson disease. Nat Rev Neurol 13(4):217–231. https://doi.org/10.1038/nrneurol.2017.27
doi: 10.1038/nrneurol.2017.27 pubmed: 28257128 pmcid: 5643027
Pillon B, Dubois B, Agid Y (1996) Testing cognition may contribute to the diagnosis of movement disorders. Neurology 46(2):329–334. https://doi.org/10.1212/wnl.46.2.329
doi: 10.1212/wnl.46.2.329 pubmed: 8614489
Hansch EC, Syndulko K, Cohen SN, Goldberg ZI, Potvin AR, Tourtellotte WW (1982) Cognition in Parkinson disease: an event-related potential perspective. Ann Neurol 11(6):599–607. https://doi.org/10.1002/ana.410110608
doi: 10.1002/ana.410110608 pubmed: 7114809
Pena J, Ibarretxe-Bilbao N, Garcia-Gorostiaga I, Gomez-Beldarrain MA, Diez-Cirarda M, Ojeda N (2014) Improving functional disability and cognition in Parkinson disease: randomized controlled trial. Neurology 83(23):2167–2174. https://doi.org/10.1212/wnl.0000000000001043
doi: 10.1212/wnl.0000000000001043 pubmed: 25361785 pmcid: 4276404
Pluck GC, Brown RG (2002) Apathy in Parkinson's disease. J Neurol Neurosurg Psychiatry 73(6):636–642. https://doi.org/10.1136/jnnp.73.6.636
doi: 10.1136/jnnp.73.6.636 pubmed: 12438462 pmcid: 1757348
Jasinska-Myga B, Putzke JD, Wider C, Wszolek ZK, Uitti RJ (2010) Depression in Parkinson's disease. Can J Neurol Sci Le journal Canadien des sciences neurologiques 37(1):61–66. https://doi.org/10.1017/s0317167100009665
doi: 10.1017/s0317167100009665
Jost WH (2003) Autonomic dysfunctions in idiopathic Parkinson's disease. J Neurol 250(Suppl 1):I28–30. https://doi.org/10.1007/s00415-003-1105-z
doi: 10.1007/s00415-003-1105-z pubmed: 12761632
Berg D, Postuma RB, Adler CH, Bloem BR, Chan P, Dubois B, Gasser T, Goetz CG, Halliday G, Joseph L, Lang AE, Liepelt-Scarfone I, Litvan I, Marek K, Obeso J, Oertel W, Olanow CW, Poewe W, Stern M, Deuschl G (2015) MDS research criteria for prodromal Parkinson's disease. Mov Disord 30(12):1600–1611. https://doi.org/10.1002/mds.26431
doi: 10.1002/mds.26431 pubmed: 26474317
Kaufmann H, Goldstein DS (2013) Autonomic dysfunction in Parkinson disease. Handbf Clin Neurol 117:259–278. https://doi.org/10.1016/b978-0-444-53491-0.00021-3
doi: 10.1016/b978-0-444-53491-0.00021-3
Velseboer DC, de Haan RJ, Wieling W, Goldstein DS, de Bie RM (2011) Prevalence of orthostatic hypotension in Parkinson's disease: a systematic review and meta-analysis. Parkinsonism Relat Disord 17(10):724–729. https://doi.org/10.1016/j.parkreldis.2011.04.016
doi: 10.1016/j.parkreldis.2011.04.016 pubmed: 21571570 pmcid: 5199613
Palma JA, Gomez-Esteban JC, Norcliffe-Kaufmann L, Martinez J, Tijero B, Berganzo K, Kaufmann H (2015) Orthostatic hypotension in Parkinson disease: how much you fall or how low you go? Mov Disord 30(5):639–645. https://doi.org/10.1002/mds.26079
doi: 10.1002/mds.26079 pubmed: 25678194 pmcid: 4397106
Cutsforth-Gregory JK, Low PA (2019) Neurogenic orthostatic hypotension in parkinson disease: a primer. Neurol Ther 8(2):307–324. https://doi.org/10.1007/s40120-019-00152-9
doi: 10.1007/s40120-019-00152-9 pubmed: 31456212 pmcid: 6946781
Low PA (2008) Prevalence of orthostatic hypotension. Clin Auton Res 18(Suppl 1):8–13. https://doi.org/10.1007/s10286-007-1001-3
doi: 10.1007/s10286-007-1001-3 pubmed: 18368301
Guo Y, Xu W, Liu FT, Li JQ, Cao XP, Tan L, Wang J, Yu JT (2019) Modifiable risk factors for cognitive impairment in Parkinson's disease: A systematic review and meta-analysis of prospective cohort studies. Mov Disord 34(6):876–883. https://doi.org/10.1002/mds.27665
doi: 10.1002/mds.27665 pubmed: 30869825
Stankovic I, Petrovic I, Pekmezovic T, Markovic V, Stojkovic T, Dragasevic-Miskovic N, Svetel M, Kostic V (2019) Longitudinal assessment of autonomic dysfunction in early Parkinson's disease. Parkinsonism Relat Disord. https://doi.org/10.1016/j.parkreldis.2019.07.008
doi: 10.1016/j.parkreldis.2019.07.008 pubmed: 31320275
Sforza M, Assogna F, Rinaldi D, Sette G, Tagliente S, Pontieri FE (2018) Orthostatic hypotension acutely impairs executive functions in Parkinson's disease. Neurol Sci 39(8):1459–1462. https://doi.org/10.1007/s10072-018-3394-2
doi: 10.1007/s10072-018-3394-2 pubmed: 29627942
De Pablo-Fernandez E, Tur C, Revesz T, Lees AJ, Holton JL, Warner TT (2017) Association of autonomic dysfunction with disease progression and survival in Parkinson disease. JAMA neurology 74(8):970–976. https://doi.org/10.1001/jamaneurol.2017.1125
doi: 10.1001/jamaneurol.2017.1125 pubmed: 28655059 pmcid: 5710320
Centi J, Freeman R, Gibbons CH, Neargarder S, Canova AO, Cronin-Golomb A (2017) Effects of orthostatic hypotension on cognition in Parkinson disease. Neurology 88(1):17–24. https://doi.org/10.1212/wnl.0000000000003452
doi: 10.1212/wnl.0000000000003452 pubmed: 27903817 pmcid: 5200856
Fanciulli A, Strano S, Colosimo C, Caltagirone C, Spalletta G, Pontieri FE (2013) The potential prognostic role of cardiovascular autonomic failure in alpha-synucleinopathies. Eur J Neurol 20(2):231–235. https://doi.org/10.1111/j.1468-1331.2012.03819.x
doi: 10.1111/j.1468-1331.2012.03819.x pubmed: 22834919
Oka H, Toyoda C, Yogo M, Mochio S (2011) Cardiovascular dysautonomia in de novo Parkinson's disease without orthostatic hypotension. Eur J Neurol 18(2):286–292. https://doi.org/10.1111/j.1468-1331.2010.03135.x
doi: 10.1111/j.1468-1331.2010.03135.x pubmed: 20602633
Rocchi C, Pierantozzi M, Galati S, Chiaravalloti A, Pisani V, Prosperetti C, Lauretti B, Stampanoni Bassi M, Olivola E, Schillaci O, Stefani A (2015) Autonomic function tests and MIBG in Parkinson's disease: correlation to disease duration and motor symptoms. CNS Neurosci Ther 21(9):727–732. https://doi.org/10.1111/cns.12437
doi: 10.1111/cns.12437 pubmed: 26205884 pmcid: 6493143
Perez T, Tijero B, Gabilondo I, Luna A, Llorens V, Berganzo K, Acera M, Gonzalez A, Sanchez-Ferro A, Lezcano E, Zarranz JJ, Gomez-Esteban JC (2015) Cardiocirculatory manifestations in Parkinson's disease patients without orthostatic hypotension. J Hum Hypertens 29(10):604–609. https://doi.org/10.1038/jhh.2014.131
doi: 10.1038/jhh.2014.131 pubmed: 25631216
Wang Y, Zhao X, O'Neil A, Turner A, Liu X, Berk M (2013) Altered cardiac autonomic nervous function in depression. BMC Psychiatry 13:187. https://doi.org/10.1186/1471-244x-13-187
doi: 10.1186/1471-244x-13-187 pubmed: 23842138 pmcid: 3710510
Hughes AJ, Daniel SE, Kilford L, Lees AJ (1992) Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 55(3):181–184. https://doi.org/10.1136/jnnp.55.3.181
doi: 10.1136/jnnp.55.3.181 pubmed: 1564476 pmcid: 1014720
McKeith IG, Galasko D, Kosaka K, Perry EK, Dickson DW, Hansen LA, Salmon DP, Lowe J, Mirra SS, Byrne EJ, Lennox G, Quinn NP, Edwardson JA, Ince PG, Bergeron C, Burns A, Miller BL, Lovestone S, Collerton D, Jansen EN, Ballard C, de Vos RA, Wilcock GK, Jellinger KA, Perry RH (1996) Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology 47(5):1113–1124. https://doi.org/10.1212/wnl.47.5.1113
doi: 10.1212/wnl.47.5.1113 pubmed: 8909416
McKeith IG, Dickson DW, Lowe J, Emre M, O'Brien JT, Feldman H, Cummings J, Duda JE, Lippa C, Perry EK, Aarsland D, Arai H, Ballard CG, Boeve B, Burn DJ, Costa D, Del Ser T, Dubois B, Galasko D, Gauthier S, Goetz CG, Gomez-Tortosa E, Halliday G, Hansen LA, Hardy J, Iwatsubo T, Kalaria RN, Kaufer D, Kenny RA, Korczyn A, Kosaka K, Lee VM, Lees A, Litvan I, Londos E, Lopez OL, Minoshima S, Mizuno Y, Molina JA, Mukaetova-Ladinska EB, Pasquier F, Perry RH, Schulz JB, Trojanowski JQ, Yamada M (2005) Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology 65(12):1863–1872. https://doi.org/10.1212/01.wnl.0000187889.17253.b1
doi: 10.1212/01.wnl.0000187889.17253.b1 pubmed: 16237129
Litvan I, Goldman JG, Troster AI, Schmand BA, Weintraub D, Petersen RC, Mollenhauer B, Adler CH, Marder K, Williams-Gray CH, Aarsland D, Kulisevsky J, Rodriguez-Oroz MC, Burn DJ, Barker RA, Emre M (2012) Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelines. Mov Disord 27(3):349–356. https://doi.org/10.1002/mds.24893
doi: 10.1002/mds.24893 pubmed: 22275317 pmcid: 3641655
Evatt ML, Chaudhuri KR, Chou KL, Cubo E, Hinson V, Kompoliti K, Yang C, Poewe W, Rascol O, Sampaio C, Stebbins GT, Goetz CG (2009) Dysautonomia rating scales in Parkinson's disease: sialorrhea, dysphagia, and constipation–critique and recommendations by movement disorders task force on rating scales for Parkinson's disease. Mov Disord 24(5):635–646. https://doi.org/10.1002/mds.22260
doi: 10.1002/mds.22260 pubmed: 19205066 pmcid: 4404514
Novak P (2011) Quantitative autonomic testing. J Vis Exp. https://doi.org/10.3791/2502
doi: 10.3791/2502 pubmed: 21788940 pmcid: 3196175
Consensus statement on the definition of orthostatic hypotension, pure autonomic failure, and multiple system atrophy. The Consensus Committee of the American Autonomic Society and the American Academy of Neurology (1996). Neurology 46 (5):1470. doi:10.1212/wnl.46.5.1470
Casellini CM, Parson HK, Richardson MS, Nevoret ML, Vinik AI (2013) Sudoscan, a noninvasive tool for detecting diabetic small fiber neuropathy and autonomic dysfunction. Diabetes Technol Ther 15(11):948–953. https://doi.org/10.1089/dia.2013.0129
doi: 10.1089/dia.2013.0129 pubmed: 23889506 pmcid: 3817891
Allcock LM, Kenny RA, Mosimann UP, Tordoff S, Wesnes KA, Hildreth AJ, Burn DJ (2006) Orthostatic hypotension in Parkinson's disease: association with cognitive decline? Int J Geriatr Psychiatry 21(8):778–783. https://doi.org/10.1002/gps.1562
doi: 10.1002/gps.1562 pubmed: 16906622
Peralta C, Stampfer-Kountchev M, Karner E, Kollensperger M, Geser F, Wolf E, Seppi K, Benke T, Poewe W, Wenning GK (2007) Orthostatic hypotension and attention in Parkinson's disease with and without dementia. J Neural Transm (Vienna, Austria: 1996) 114(5):585–588. https://doi.org/10.1007/s00702-006-0615-2
doi: 10.1007/s00702-006-0615-2
Robertson AD, Messner MA, Shirzadi Z, Kleiner-Fisman G, Lee J, Hopyan J, Lang AE, Black SE, MacIntosh BJ, Masellis M (2016) Orthostatic hypotension, cerebral hypoperfusion, and visuospatial deficits in Lewy body disorders. Parkinsonism Relat Disord 22:80–86. https://doi.org/10.1016/j.parkreldis.2015.11.019
doi: 10.1016/j.parkreldis.2015.11.019 pubmed: 26639982
Paschali A, Messinis L, Kargiotis O, Lakiotis V, Kefalopoulou Z, Constantoyannis C, Papathanasopoulos P, Vassilakos P (2010) SPECT neuroimaging and neuropsychological functions in different stages of Parkinson's disease. Eur J Nucl Med Mol Imaging 37(6):1128–1140. https://doi.org/10.1007/s00259-010-1381-9
doi: 10.1007/s00259-010-1381-9 pubmed: 20145921
Chung SJ, Bae YJ, Jun S, Yoo HS, Kim SW, Lee YH, Sohn YH, Lee SK, Seong JK, Lee PH (2019) Dysautonomia is associated with structural and functional alterations in Parkinson disease. Neurology 92(13):e1456–e1467. https://doi.org/10.1212/wnl.0000000000007181
doi: 10.1212/wnl.0000000000007181 pubmed: 30796135
Rocchi C, Placidi F, Liguori C, Del Bianco C, Lauretti B, Diomedi M, Pisani A, Mercuri NB, Izzi F (2018) Daytime autonomic activity in idiopathic rapid eye movement sleep behavior disorder: a preliminary study. Sleep Med 52:163–167. https://doi.org/10.1016/j.sleep.2018.08.023
doi: 10.1016/j.sleep.2018.08.023 pubmed: 30359891
Postuma RB, Lang AE, Massicotte-Marquez J, Montplaisir J (2006) Potential early markers of Parkinson disease in idiopathic REM sleep behavior disorder. Neurology 66(6):845–851. https://doi.org/10.1212/01.wnl.0000203648.80727.5b
doi: 10.1212/01.wnl.0000203648.80727.5b pubmed: 16567700
Schmidt C, Herting B, Prieur S, Junghanns S, Schweitzer K, Globas C, Schols L, Reichmann H, Berg D, Ziemssen T (2009) Valsalva manoeuvre in patients with different Parkinsonian disorders. J Neural Transm (Vienna, Austria: 1996) 116(7):875–880. https://doi.org/10.1007/s00702-009-0239-4
doi: 10.1007/s00702-009-0239-4
Fereshtehnejad SM, Lökk J (2014) Orthostatic hypotension in patients with Parkinson's disease and atypical parkinsonism. Parkinson's Dis. https://doi.org/10.1155/2014/475854
doi: 10.1155/2014/475854
Carmona-Abellan M, Gabilondo I, Murueta-Goyena A, Khurana V, Tijero B, Luquin MR, Acera M, Del Pino R, Gardeazabal J, Martinez-Valbuena I, Sanchez-Pernaute R, Gomez-Esteban JC (2019) Small fiber neuropathy and phosphorylated alpha-synuclein in the skin of E46K-SNCA mutation carriers. Parkinsonism Relat Disord 65:139–145. https://doi.org/10.1016/j.parkreldis.2019.05.038
doi: 10.1016/j.parkreldis.2019.05.038 pubmed: 31178336
Siepmann T, Illigens BM-W, Barlinn K (2016) Alpha-synuclein in cutaneous small nerve fibers. Neuropsychiatr Dis Treat 12:2731–2735. https://doi.org/10.2147/NDT.S117423
doi: 10.2147/NDT.S117423 pubmed: 27822045 pmcid: 5087811
Amino T, Orimo S, Itoh Y, Takahashi A, Uchihara T, Mizusawa H (2005) Profound cardiac sympathetic denervation occurs in Parkinson disease. Brain Pathol (Zurich, Switzerland) 15(1):29–34. https://doi.org/10.1111/j.1750-3639.2005.tb00097.x
doi: 10.1111/j.1750-3639.2005.tb00097.x
Seidel K, Mahlke J, Siswanto S, Kruger R, Heinsen H, Auburger G, Bouzrou M, Grinberg LT, Wicht H, Korf HW, den Dunnen W, Rub U (2015) The brainstem pathologies of Parkinson's disease and dementia with Lewy bodies. Brain Pathol (Zurich, Switzerland) 25(2):121–135. https://doi.org/10.1111/bpa.12168
doi: 10.1111/bpa.12168
Palma JA, Carmona-Abellan MM, Barriobero N, Trevino-Peinado C, Garcia-Lopez M, Fernandez-Jarne E, Luquin MR (2013) Is cardiac function impaired in premotor Parkinson's disease? A retrospective cohort study. Mov Disord 28(5):591–596. https://doi.org/10.1002/mds.25431
doi: 10.1002/mds.25431 pubmed: 23483644
Kim JS, Oh YS, Lee KS, Kim YI, Yang DW, Goldstein DS (2012) Association of cognitive dysfunction with neurocirculatory abnormalities in early Parkinson disease. Neurology 79(13):1323–1331. https://doi.org/10.1212/WNL.0b013e31826c1acd
doi: 10.1212/WNL.0b013e31826c1acd pubmed: 22972639 pmcid: 3448741
Forte G, Favieri F, Casagrande M (2019) Heart rate variability and cognitive function: a systematic review. Front Neurosci 13:710. https://doi.org/10.3389/fnins.2019.00710
doi: 10.3389/fnins.2019.00710 pubmed: 31354419 pmcid: 6637318
Solopchuk O, Sebti M, Bouvy C, Benoit CE, Warlop T, Jeanjean A, Zenon A (2018) Locus Coeruleus atrophy doesn't relate to fatigue in Parkinson's disease. Sci Rep 8(1):12381. https://doi.org/10.1038/s41598-018-30128-y
doi: 10.1038/s41598-018-30128-y pubmed: 30120287 pmcid: 6098016
Remy P, Doder M, Lees A, Turjanski N, Brooks D (2005) Depression in Parkinson's disease: loss of dopamine and noradrenaline innervation in the limbic system. Brain J Neurol 128(Pt 6):1314–1322. https://doi.org/10.1093/brain/awh445
doi: 10.1093/brain/awh445
Loued-Khenissi L, Preuschoff K (2015) Apathy and noradrenaline: silent partners to mild cognitive impairment in Parkinson's disease? Curr Opin Neurol 28(4):344–350. https://doi.org/10.1097/wco.0000000000000218
doi: 10.1097/wco.0000000000000218 pubmed: 26110801
Olivola E, Brusa L, Rocchi C, Schillaci O, Liguori C, Cerroni R, Pierantozzi M, Chiaravalloti A, Stefani A, Stocchi F (2018) Does fatigue in Parkinson's disease correlate with autonomic nervous system dysfunction? Neurol Sci 39(12):2169–2174. https://doi.org/10.1007/s10072-018-3569-x
doi: 10.1007/s10072-018-3569-x pubmed: 30255487
Chou KL, Gilman S, Bohnen NI (2017) Association between autonomic dysfunction and fatigue in Parkinson disease. J Neurol Sci 377:190–192. https://doi.org/10.1016/j.jns.2017.04.023
doi: 10.1016/j.jns.2017.04.023 pubmed: 28477694 pmcid: 5536106
Sambati L, Calandra-Buonaura G, Poda R, Guaraldi P, Cortelli P (2014) Orthostatic hypotension and cognitive impairment: a dangerous association? Neurol Sci 35(6):951–957. https://doi.org/10.1007/s10072-014-1686-8
doi: 10.1007/s10072-014-1686-8 pubmed: 24590841

Auteurs

Rocío Del Pino (R)

Neurodegenerative Diseases Group, Biocruces Bizkaia Health Research Institute, Plaza de Cruces 12, CP, 48903, Barakaldo, Bizkaia, Spain. delpinorocio@gmail.com.
International University of La Rioja, La Rioja, Spain. delpinorocio@gmail.com.

Ane Murueta-Goyena (A)

Neurodegenerative Diseases Group, Biocruces Bizkaia Health Research Institute, Plaza de Cruces 12, CP, 48903, Barakaldo, Bizkaia, Spain.

Marian Acera (M)

Neurodegenerative Diseases Group, Biocruces Bizkaia Health Research Institute, Plaza de Cruces 12, CP, 48903, Barakaldo, Bizkaia, Spain.

Mar Carmona-Abellan (M)

Neurodegenerative Diseases Group, Biocruces Bizkaia Health Research Institute, Plaza de Cruces 12, CP, 48903, Barakaldo, Bizkaia, Spain.

Beatriz Tijero (B)

Neurodegenerative Diseases Group, Biocruces Bizkaia Health Research Institute, Plaza de Cruces 12, CP, 48903, Barakaldo, Bizkaia, Spain.
Neurology Department, Cruces University Hospital, Barakaldo, Bizkaia, Spain.

Olaia Lucas-Jiménez (O)

Department of Methods and Experimental Psychology, Faculty of Psychology and Education, University of Deusto, Bilbao, Spain.

Natalia Ojeda (N)

Department of Methods and Experimental Psychology, Faculty of Psychology and Education, University of Deusto, Bilbao, Spain.

Naroa Ibarretxe-Bilbao (N)

Department of Methods and Experimental Psychology, Faculty of Psychology and Education, University of Deusto, Bilbao, Spain.

Javier Peña (J)

Department of Methods and Experimental Psychology, Faculty of Psychology and Education, University of Deusto, Bilbao, Spain.

Iñigo Gabilondo (I)

Neurodegenerative Diseases Group, Biocruces Bizkaia Health Research Institute, Plaza de Cruces 12, CP, 48903, Barakaldo, Bizkaia, Spain.
Neurology Department, Cruces University Hospital, Barakaldo, Bizkaia, Spain.
Ikerbasque: The Basque Foundation for Science, Bilbao, Spain.

Juan Carlos Gómez-Esteban (JC)

Neurodegenerative Diseases Group, Biocruces Bizkaia Health Research Institute, Plaza de Cruces 12, CP, 48903, Barakaldo, Bizkaia, Spain.
Neurology Department, Cruces University Hospital, Barakaldo, Bizkaia, Spain.
Department of Neurosciences, University of the Basque Country (UPV/EHU), Leioa, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH